NCT07544121 2026-04-22
Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis
Nanfang Hospital, Southern Medical University
Phase NA Not yet recruiting
Clinical Trials
14 trialsNCT07481032 2026-03-18
Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
Nanfang Hospital, Southern Medical University
Phase NA Not yet recruiting
NCT07298577 2025-12-23
STOPHCC-GAAD
Siriraj Hospital
Phase NA Not yet recruiting
NCT04294498 2025-03-26
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
National Taiwan University Hospital
Phase 2 Active not recruiting
NCT05671315 2023-05-25
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
Ruijin Hospital
Phase NA Recruiting
NCT05721300 2023-02-10
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
Zhongshan Hospital (Xiamen), Fudan University
Phase NA Unknown
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT02081469 2020-02-05
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy
Chang Gung Memorial Hospital
Phase 4 Completed
NCT02289300 2020-01-13
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
A2 Healthcare Taiwan Corporation
Phase 2 Withdrawn
NCT00397540 2019-03-18
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Phase NA Completed
NCT02991638 2018-04-12
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
The University of Hong Kong
Phase 3 Unknown
NCT03253250 2017-09-08
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
Huashan Hospital
Phase 4 Unknown
NCT02779465 2016-05-20
VDHCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4 Not yet recruiting
NCT01872988 2014-09-04
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 3 Terminated